ArticleNature nanotechnology2026
Glycan atlassing enables functional tracing of cell state.
Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Myelin Dynamics at the Axon-Oligodendrocyte Interface: Adaptive Conduction Homeostasis in Demyelination, Remyelination and White Matter Repair.International journal of molecular sciences · 2026Review
- Glycan atlassing enables functional tracing of cell state.Nature nanotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The glycocalyx is a complex layer of glycosylated molecules that surrounds all cells in the human body. It is involved in regulating critical cellular processes, including immune response modulation, cell adhesion and host-pathogen interactions. Despite these insights, the functional relationship between the glycocalyx architecture and cellular state has remained elusive, largely due to the structural diversity of glycocalyx constituents and their nanoscale organization. Here we show that DNA-tagged lectin labelling and metabolic oligosaccharide engineering enable multiplexed super-resolution microscopy of the glycocalyx constituents, yielding an atlas of glycocalyx architecture with nanometre resolution. Quantitative analysis of the obtained nanoscale map of glycocalyx constituents facilitates the extraction of characteristic spatial relationships that accurately report on the cellular state. We demonstrate the capacity of our approach, which we term glycan atlassing, across cell and tissue types, ranging from cultured cell lines to primary immune cells, neurons and primary patient tissue. Glycan atlassing establishes a transformative strategy for investigating glycocalyx remodelling in development and disease, potentially enabling the development of glycocalyx-centred targets in diagnosis and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.